Natixis’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-250
Closed -$11.9K 1097
2023
Q3
$11.9K Sell
250
-4,700
-95% -$224K ﹤0.01% 874
2023
Q2
$474K Buy
+4,950
New +$474K ﹤0.01% 634